Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 4—April 2020
Synopsis

Imported Arbovirus Infections in Spain, 2009–2018

Francesca F. NormanComments to Author , César Henríquez-Camacho, Marta Díaz-Menendez, Sandra Chamorro, Diana Pou, Israel Molina, Josune Goikoetxea, Azucena Rodríguez-Guardado, Eva Calabuig, Clara Crespillo, Inés Oliveira, José-Antonio Pérez-Molina, Rogelio López-Velez, and for the Redivi Study Group
Author affiliations: Ramón y Cajal University Hospital, Madrid, Spain (F.F. Norman, C. Henríquez-Camacho, S. Chamorro, J.-A. Pérez-Molina, R. López-Velez); La Paz-Carlos III Hospital, Madrid (M. Díaz-Menendez, C. Crespillo); Vall d’Hebron-Drassanes, Barcelona, Spain (D. Pou, I. Molina, I. Oliveira); Cruces University Hospital, Bilbao, Spain (J. Goikoetxea); Asturias Central University Hospital, Oviedo, Spain (A. Rodríguez-Guardado); La Fe de Valencia University Hospital, Valencia, Spain (E. Calabuig)

Main Article

Table 2

Main characteristics of patients with arbovirus monoinfections, by virus type, Spain, 2009–2018*

Characteristic Dengue, n = 456 Chikungunya, n = 280 Zika, n = 109 p value
Median age (IQR), y
 34 (29-43)
 41 (34-52)
 36 (30-43)
 <0.001
Sex, no. (%) 0.001
F 262 (57.5) 198 (70.7) 66 (60.6)
M
 194 (42.5)
 82 (29.3)
 43 (39.4)
Type of patient <0.001
Immigrant 14 8 1
VFR immigrant 93 162 53
VFR traveler 9 7 5
Traveler
 340
 103
 50
Region, no. (%) <0.001
Sub-Saharan Africa 39 (8.6) 16 (5.7) 5 (4.6)
North America 1 (0.2) 0 1 (0.9)
Central America and Caribbean 89 (19.6) 94 (33.6) 53 (48.6)
South America 105 (23.1) 139 (49.6) 48 (44.0)
South-central Asia 58 (12.8) 11 (3.9) 1 (0.9)
Eastern Asia 2 (0.4) 0 0
Southeast Asia 156 (34.3) 17 (6.1) 1 (1.0)
Australasia 3 (0.7) 2 (0.7) 0
Europe
 1 (0.2)
 1 (0.4)
 0
Median no. travel days (IQR) 25 (15-36) 31 (25-66) 30 (20-59) <0.001
Median no. weeks until first consultation (IQR) 1.1 (0.4-3.1) 3 (1.0-7.1) 1.2 (0.6-3.3) <0.001
Travel >30 d, no. (%) 133 (30.1) 135 (50.2) 41 (38.0) <0.001
Pretravel advice, no. (%) 175 (39.7) 55 (20.4) 12 (11.1) <0.001
Immunosuppression (%) 6 (1.3) 4 (1.4) 2 (1.8) 0.919

*IQR, interquartile range; VFR, visiting friends and relatives.

Main Article

Page created: March 17, 2020
Page updated: August 10, 2020
Page reviewed: August 10, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external